ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
Ataxia patient care pathway and associated healthcare costs in Italy: a cross-sectional survey.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Friedreich's ataxia patient pathway in Europe.Frontiers in health services · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe ataxias are rare complex neurological disorders challenging for clinicians to manage. The costs of ataxia care and differences in healthcare use and treatment outcomes between specialised ataxia centres (SAC) and standard neurology services have not been investigated.
objectiveThis study explored patient pathways, healthcare use and costs, comparing SAC with non-specialist settings in Italy.
methodsA patient survey was distributed in Italy (May-September 2021) to collect information about the diagnosis and management of ataxias in SAC and non-specialist settings, healthcare service visits, and patients' satisfaction. We compared per-patient mean resource use for each contact type and health service cost, stratifying patients by SAC attendance.
resultsAmong 174 participants, 44% saw a neurologist within 6 months of seeking medical advice, and 56% went to a SAC directly. Travelling was a top reason why people stopped going to a SAC and a barrier preventing patients from accessing it. SACs delivered better service to patients in various aspects of care. The differences in the number of contacts for various health services between the SAC and non-SAC groups were mostly non-significant. The mean total cost per patient over a one-year period was €1952 for non-SAC and €1666 for SAC.
conclusionsThere was a trend towards patients' appreciation for SAC services compared with non-SAC services, without significant change in costs. We identified difficulties in attendance and adherence despite the significant number of SACs in Italy. We believe that the combination of face-to-face and telemedicine could improve patients' attendance at SACs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.